ArticleTranslational cancer research2022

Anlotinib combined with temozolomide for the treatment of patients with diffuse midline glioma: a case report and literature review.

Yiping Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.